Metalo-β-lactamases in clinical isolates of Pseudomonas aeruginosa in Lima, Peru;Metalo-β-lactamasas en aislamientos clínicos de Pseudomonas aeruginosa en Lima, Perú

Revista Peruana de Medicina Experimental y Salud Publica

Volumn 30, Issue 2, 2013, Pages 241-245

  Gonzales Escalante, Edgar ^a   Vicente Taboada, William ^b   Champi Merino, Roky ^c   Soto Pastrana, Javier ^d   Flores Paredes, Wilfredo ^e   Lovera García, Margarita ^e   Chuquiray Valverde, Nancy ^f   Bejarano Cristobal, Carlos ^f   Puray Chávez, Maritza ^g   León Sandoval, Segundo ^g  

^a INSTITUTO NACIONAL DE SALUD DEL NIÑO   (Peru)

^b INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^c Hospital Nacional Hipólito Unanue   (Peru)

^d HOSPITAL NACIONAL DOCENTE MADRE NIÑO SAN BARTOLOMÉ   (Peru)

^e HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^f HOSPITAL NACIONAL ALBERTO SABOGAL SOLOGUREN   (Peru)

^g Universidad Nacional Mayor de San Marcos   (Peru)

Author keywords

Bacterial; Drug resistance; Genes; Ltidrug resistance associated proteins; MDR; Penicillinase; Pseudomonas aeruginosa

Indexed keywords

CARBAPENEM DERIVATIVE; CEFTAZIDIME; EDETIC ACID; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CROSS-SECTIONAL STUDY; ENZYME ASSAY; NONHUMAN; PERU; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; DRUG EFFECT; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS-SECTIONAL STUDIES; HUMANS; MICROBIAL SENSITIVITY TESTS; PERU; PSEUDOMONAS AERUGINOSA;

EID: 84882610523     PISSN: 17264634     EISSN: 17264642     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Classics in infectious diseases. On the blue and green coloration that appears on bandages. By Carle Gessard (1850-1925). Rev Infect Dis. 1984;6 Suppl 3:S775-6
2. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S146-55.
3. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother. 2001;47(3):247-50.
4. Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol. 2000;3(5):489-95.
5. Walsh T, Toleman M, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005;18(2):0306-25.
6. Queenan A, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440-58.
7. Rasmussen BA, Bush K. Carbapenem-hydrolyzing beta-lactamases. Antimicrob Agents Chemother. 1997;41(2):223-32.
8. Bebrone C. Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol. 2007;74(12):1686-1701.
9. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-b-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol. 2000;38(1):40-3.
10. Radice M, Marín M, Giovanakis M, Vay C, Almuzara M, Limansky A, et al. Criterios de ensayo, interpretación e informe de las pruebas de sensibilidad a los antibióticos en los bacilos gram negativos no fermentadores de importancia clínica: recomendaciones de la Subcomisión de Antimicrobianos de la Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas, Asociación Argentina de Microbiología. Rev Argent Microbiol. 2011;43(2):136-53.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement. M100-S22. Wayne PA: Clinical and Laboratory Standards Institute; 2012.
12. Ellington M, Kistler J, Livermore D, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59(2):321-2.
13. Pagniez G, Radice M, Cuirolo A, Rodríguez O, Rodríguez H, Vay C, et al. Prevalencia de metalo-β-lactamasas en Pseudomonas aeruginosa resistentes a carbapenemes en un hospital universitario de Buenos Aires. Rev Argent Microbiol. 2006;38(1):33-7.
14. Cejas D, Almuzara M, Santella G, Tuduri A, Palombarani S, Figueroa S, et al. Caracterización fenotípica y genotípica de la resistencia a imipenem en Pseudomonas aeruginosa aisladas en un hospital de Buenos Aires. Rev Argent Microbiol. 2008;40:238-245
15. Pérez A, García P, Poggi H, Braun S, Castillo C, Román J, et al. Presencia de metalo-ß-lactamasas en Pseudomonas aeruginosa resistente a imipenem. Rev Méd Chile. 2008;136:423-32.
16. Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN. Dissemination and diversity of metallo-b-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents. 2005;25(1):57-61.
17. Farra A, Islam S, Stralfors A, Sorberg M, Wretlind B. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Int J of Antimicrob Agents. 2008;31(5):427-33.
18. Pages JM, Amaral L. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta. 2009;1794(5):826-33.
19. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003;2(1):48-62.
20. Bush K, Jacoby GA. Updated functional classification of ß-lactamases. Antimicrob. Agents. Chemother. 2010;54(3):969-76.